Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4580652
Max Phase: Preclinical
Molecular Formula: C42H70N6O27
Molecular Weight: 1091.04
Molecule Type: Unknown
Associated Items:
ID: ALA4580652
Max Phase: Preclinical
Molecular Formula: C42H70N6O27
Molecular Weight: 1091.04
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CC(=O)N[C@H]1[C@H](OCCCCCCN=[N+]=[N-])O[C@H](CO)[C@@H](O[C@@H]2O[C@H](CO)[C@H](O)[C@H](O[C@]3(C(=O)O)C[C@H](O)[C@@H](NC(C)=O)[C@H]([C@@H](O)[C@@H](CO)O[C@]4(C(=O)O)C[C@H](O)[C@@H](NC(C)=O)[C@H]([C@H](O)[C@H](O)CO)O4)O3)[C@H]2O)[C@@H]1O
Standard InChI: InChI=1S/C42H70N6O27/c1-16(53)45-25-19(56)10-41(39(64)65,73-34(25)28(59)21(58)12-49)72-23(14-51)30(61)35-26(46-17(2)54)20(57)11-42(74-35,40(66)67)75-36-29(60)22(13-50)69-38(32(36)63)71-33-24(15-52)70-37(27(31(33)62)47-18(3)55)68-9-7-5-4-6-8-44-48-43/h19-38,49-52,56-63H,4-15H2,1-3H3,(H,45,53)(H,46,54)(H,47,55)(H,64,65)(H,66,67)/t19-,20-,21+,22+,23+,24+,25+,26+,27+,28+,29-,30-,31+,32+,33+,34+,35+,36-,37+,38-,41+,42-/m0/s1
Standard InChI Key: CGZHTDQIIXPKAX-UJBTXCHYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1091.04 | Molecular Weight (Monoisotopic): 1090.4289 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Wu HR, Anwar MT, Fan CY, Low PY, Angata T, Lin CC.. (2019) Expedient assembly of Oligo-LacNAcs by a sugar nucleotide regeneration system: Finding the role of tandem LacNAc and sialic acid position towards siglec binding., 180 [PMID:31351394] [10.1016/j.ejmech.2019.07.046] |
Source(1):